Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

This study has been completed.
Information provided by (Responsible Party):
Boehringer Ingelheim Identifier:
First received: April 10, 2012
Last updated: October 26, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)